Monopar Therapeutics (MNPR) Preferred Shares (2016)
Monopar Therapeutics (MNPR) has disclosed Preferred Shares for 1 consecutive years, with $116.0 as the latest value for Q4 2016.
- Quarterly Preferred Shares changed N/A to $116.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $116.0 through Dec 2016, changed N/A year-over-year, with the annual reading at $116.0 for FY2016, N/A changed from the prior year.
- Preferred Shares hit $116.0 in Q4 2016 for Monopar Therapeutics.
- In the past five years, Preferred Shares ranged from a high of $116.0 in Q4 2016 to a low of $116.0 in Q4 2016.